CN101141979B - 猫变应原融合蛋白及其用途 - Google Patents

猫变应原融合蛋白及其用途 Download PDF

Info

Publication number
CN101141979B
CN101141979B CN2006800088726A CN200680008872A CN101141979B CN 101141979 B CN101141979 B CN 101141979B CN 2006800088726 A CN2006800088726 A CN 2006800088726A CN 200680008872 A CN200680008872 A CN 200680008872A CN 101141979 B CN101141979 B CN 101141979B
Authority
CN
China
Prior art keywords
compositions
fel
seq
attachment site
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006800088726A
Other languages
English (en)
Chinese (zh)
Other versions
CN101141979A (zh
Inventor
M·巴克曼
M·鲍尔
K·迪特迈尔
N·施米茨
S·尤特津格尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytos Biotechnology AG
Original Assignee
Cytos Biotechnology AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytos Biotechnology AG filed Critical Cytos Biotechnology AG
Publication of CN101141979A publication Critical patent/CN101141979A/zh
Application granted granted Critical
Publication of CN101141979B publication Critical patent/CN101141979B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN2006800088726A 2005-03-18 2006-03-17 猫变应原融合蛋白及其用途 Expired - Fee Related CN101141979B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66291805P 2005-03-18 2005-03-18
US60/662,918 2005-03-18
PCT/EP2006/060845 WO2006097530A2 (en) 2005-03-18 2006-03-17 Cat allergen fusion proteins and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN2013101152149A Division CN103203016A (zh) 2005-03-18 2006-03-17 猫变应原融合蛋白及其用途

Publications (2)

Publication Number Publication Date
CN101141979A CN101141979A (zh) 2008-03-12
CN101141979B true CN101141979B (zh) 2013-05-08

Family

ID=36843236

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2013101152149A Pending CN103203016A (zh) 2005-03-18 2006-03-17 猫变应原融合蛋白及其用途
CN2006800088726A Expired - Fee Related CN101141979B (zh) 2005-03-18 2006-03-17 猫变应原融合蛋白及其用途

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN2013101152149A Pending CN103203016A (zh) 2005-03-18 2006-03-17 猫变应原融合蛋白及其用途

Country Status (19)

Country Link
US (3) US7767212B2 (OSRAM)
EP (1) EP1868642B1 (OSRAM)
JP (2) JP5302671B2 (OSRAM)
KR (1) KR20070112225A (OSRAM)
CN (2) CN103203016A (OSRAM)
AU (1) AU2006224529B2 (OSRAM)
BR (1) BRPI0608455A2 (OSRAM)
CA (1) CA2599218C (OSRAM)
CY (1) CY1114171T1 (OSRAM)
DK (1) DK1868642T3 (OSRAM)
ES (1) ES2424229T3 (OSRAM)
IL (1) IL185103A0 (OSRAM)
MX (1) MX2007011160A (OSRAM)
NZ (1) NZ561040A (OSRAM)
PL (1) PL1868642T3 (OSRAM)
PT (1) PT1868642E (OSRAM)
RU (1) RU2414239C2 (OSRAM)
WO (1) WO2006097530A2 (OSRAM)
ZA (1) ZA200707413B (OSRAM)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
CA2492826C (en) 2001-09-14 2016-12-13 Cytos Biotechnology Ag Encapsulation of unmethylated cpg-containing oligonucleotides into virus-like particles: method of preparation and use
EP1532167B1 (en) * 2002-07-17 2012-01-25 Cytos Biotechnology AG Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
AU2003250110C1 (en) * 2002-07-19 2008-05-29 Novartis Ag Vaccine compositions containing amyloid beta1-6 antigen arrays
ES2424229T3 (es) * 2005-03-18 2013-09-30 Cytos Biotechnology Ag Proteínas de fusión de alérgenos de gato y utilización de las mismas
NZ569741A (en) * 2005-12-14 2012-02-24 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
WO2007113633A2 (en) * 2006-04-03 2007-10-11 Pfizer Products Inc. Immunogenic compositions comprising cat allergen fel dl
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
JP5437797B2 (ja) 2006-06-12 2014-03-12 サイトス バイオテクノロジー アーゲー Ｒｎａバクテリオファージのウイルス様粒子にオリゴヌクレオチドをパッケージ化するための方法
SG10202012986SA (en) 2006-09-29 2021-01-28 Ligocyte Pharmaceuticals Inc Norovirus vaccine formulations
US8454953B2 (en) * 2007-07-09 2013-06-04 Nestec Sa Methods for reducing allergies caused by environmental allergens
US9388236B2 (en) 2007-07-09 2016-07-12 Nestec Sa Methods for reducing allergies caused by environmental allergens
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
CN101918028B (zh) 2007-09-18 2015-01-07 莱戈赛特医药股份有限公司 赋予针对诺如病毒的保护性免疫应答的疫苗
EP2042193A1 (en) * 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
DK2324113T3 (en) 2008-08-08 2018-04-16 Takeda Vaccines Inc VIRUS-LIKE PARTICLES INCLUDING COMPOSITE CAPSID AMINO ACID SEQUENCES FOR INCREASED CRYSTAL REACTIVITY
GB2498323B8 (en) * 2009-11-05 2014-08-06 Hal Padgett Generation of antigenic virus-like particles through protein-protein linkages
US8321012B2 (en) 2009-12-22 2012-11-27 The Invention Science Fund I, Llc Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject
MX356586B (es) 2011-07-11 2018-06-05 Takeda Vaccines Inc Formulaciones parenterales de vacunas contra los norovirus.
HK1200849A1 (en) 2011-12-22 2015-08-14 F. Hoffmann-La Roche Ag Full length antibody display system for eukaryotic cells and its use
JO3820B1 (ar) 2012-05-03 2021-01-31 Regeneron Pharma أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها
WO2014066443A1 (en) * 2012-10-23 2014-05-01 Emory University Gm-csf and il-4 conjugates, compositions, and methods related thereto
WO2015027154A2 (en) 2013-08-23 2015-02-26 Regeneron Pharmaceuticals, Inc. Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit)
JP2017512213A (ja) 2013-12-19 2017-05-18 ネステク ソシエテ アノニム 環境中のネコアレルゲンを減少するための組成物及び方法
MA40824A (fr) 2014-10-22 2017-08-29 Saiba Gmbh Particules de cmv de type virus modifié
DE16703049T1 (de) 2015-01-15 2018-07-12 University Of Copenhagen Virusähnliche partikel mit effizienter epitopanzeige
WO2016192788A1 (en) * 2015-06-03 2016-12-08 Universität Zürich Prorektorat Mnw Methods and compositions for preventing and treating cat or dog dander allergy
CA2995003A1 (en) * 2015-09-08 2017-03-16 Universitat Zurich Compositions against cat allergy
ES2854726T3 (es) 2015-10-30 2021-09-22 The Univ Of Copenhagen Partícula similar a virus con presentación eficiente de epítopos
CN105219742A (zh) * 2015-11-10 2016-01-06 海南大学 一种展示重组猫致敏原rFel d 1蛋白的免疫增强型病毒样颗粒、其表达载体及其制备与应用
WO2017179025A1 (en) 2016-04-15 2017-10-19 Alk-Abelló A/S Epitope polypeptides of ragweed pollen allergens
FR3054547B1 (fr) * 2016-07-29 2020-06-05 Angany Inc. Particules pseudo-virales et leurs utilisations
WO2018118713A1 (en) 2016-12-22 2018-06-28 Regeneron Pharmaceuticals, Inc. Method of treating an allergy with allergen-specific monoclonal antibodies
IL319030A (en) 2018-12-20 2025-04-01 Saiba AG CMV virus-like particles modified by fusion
US20250197454A1 (en) * 2022-03-18 2025-06-19 Denka Company Limited Virus-like particle containing capsid proteins connected by linker
CN114933639B (zh) * 2022-05-05 2023-12-29 中国农业科学院兰州兽医研究所 非洲猪瘟病毒p72N抗原表位蛋白及其制备方法和用途
CN117004650B (zh) * 2023-06-25 2024-05-14 山东立菲生物产业有限公司 一种猫皮屑过敏原组分feld1双链二聚体重组蛋白、制备方法及应用
WO2025139524A1 (zh) * 2023-12-28 2025-07-03 江苏众红生物工程创药研究院有限公司 猫重组变应原及其药用组合物、制备方法和应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163778A (en) * 1978-05-04 1979-08-07 The Foundation for the Study of Asthma and Related Diseases Asthma immunotherapy
US5374426A (en) * 1986-09-03 1994-12-20 University Of Saskatchewan Rotavirus nucleocapsid protein VP6 in vaccine compositions
DE68924850T2 (de) * 1988-06-14 1996-10-10 Cell Med Inc Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
US6120769A (en) * 1989-11-03 2000-09-19 Immulogic Pharmaceutical Corporation Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
JPH06503821A (ja) 1990-12-20 1994-04-28 スミスクライン・ビーチャム・バイオロジカルス（ソシエテ・アノニム） Ｂ型肝炎表面抗原に基づくワクチン
GB9114003D0 (en) * 1991-06-28 1991-08-14 Mastico Robert A Chimaeric protein
GB9213601D0 (en) * 1992-06-26 1992-08-12 Mastico Robert A Protein based delivery system
JPH10505356A (ja) 1994-09-02 1998-05-26 イミユロジク・フアーマシユーチカル・コーポレーシヨン ヒトへの投与のための組成物および方法、抗原特異的免疫応答のダウンレギュレーションを行うことが可能なペプチド
US6759234B1 (en) * 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
CN1185811A (zh) 1995-03-31 1998-06-24 H·沃尔夫 依赖于逆转录病毒样颗粒的抗原呈递系统
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
CA2315537A1 (en) * 1997-12-16 1999-06-24 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
AR020102A1 (es) 1998-07-30 2002-04-10 Ucb Sa Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
WO2000020032A1 (en) 1998-10-06 2000-04-13 Trustees Of Dartmouth College RECOMBINANT CAT ALLERGEN, Fel dI, EXPRESSED IN BACULOVIRUS FOR DIAGNOSIS AND TREATMENT OF CAT ALLERGY
AU770802B2 (en) * 1998-10-21 2004-03-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Virus-like particles for the induction of autoantibodies
DE69939836D1 (de) * 1998-11-30 2008-12-11 Cytos Biotechnology Ag Molekulare anordnung von allergenen, verfahren zur deren herstellung und deren verwendung
PL354997A1 (en) 1999-09-25 2004-03-22 University Of Iowa Research Foundation Immunostimulatory nucleic acids
CA2407897A1 (en) 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
DE60136653D1 (de) 2000-11-16 2009-01-02 Alk Abello As Mutante allergene
EP1219300B1 (en) 2000-12-28 2006-12-06 BIOMAY Produktions- und Handels- Aktiengesellschaft Treatment of allergies
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
CN1610556A (zh) 2001-03-02 2005-04-27 洛克菲勒大学 保留天然变应原的免疫原性并具减弱的变应原性的重组杂合变应原构建体
JP4360906B2 (ja) 2001-09-14 2009-11-11 サイトス バイオテクノロジー アーゲー ウィルス様粒子によって誘導される免疫応答を高めるための、抗原提示細胞のインビボでの活性化
CA2492826C (en) 2001-09-14 2016-12-13 Cytos Biotechnology Ag Encapsulation of unmethylated cpg-containing oligonucleotides into virus-like particles: method of preparation and use
BR0213941A (pt) * 2001-11-07 2004-08-31 Cytos Biotechnology Ag Arranjos de antìgeno para o tratamento de doença óssea
IL161147A0 (en) * 2001-11-07 2004-08-31 Cytos Biotechnology Ag Antigen arrays presenting il-5, il-3, or eotaxin for treatment of allergic eosinophilic diseases
EP1532167B1 (en) * 2002-07-17 2012-01-25 Cytos Biotechnology AG Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
NZ537001A (en) 2002-07-19 2007-04-27 Cytos Biotechnology Ag A composition comprising a virus-like particle and at least ghrelin or a ghrelin-derived peptide bound thereto
WO2004018506A2 (en) * 2002-08-22 2004-03-04 Cytos Biotechnology Ag Inducible alphaviral/orip based gene expression system
WO2004039834A2 (en) 2002-11-01 2004-05-13 Alk-Abelló A/S Recombinant protein variants
AU2003280324A1 (en) 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
ZA200507562B (en) * 2003-03-26 2006-11-29 Cytos Biotechnology Ag HIV-peptide-carrier-conjugates
DK1620554T3 (da) 2003-04-24 2008-06-02 Imvision Gmbh Rekombinant Fel d 1-allergen
KR20060031607A (ko) * 2003-07-10 2006-04-12 사이토스 바이오테크놀로지 아게 패킹된 바이러스-양 입자
ES2424229T3 (es) * 2005-03-18 2013-09-30 Cytos Biotechnology Ag Proteínas de fusión de alérgenos de gato y utilización de las mismas

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Hans Gronlund et al..Formation of Disulfide Bonds and Homodimers of the Major Cat Allergen Fel d1 Equivalent to the Natural Allergen by Expression in Escherichia coli.THE JOURNAL OF BIOLOGICAL CHEMISTRY.2003,(41),摘要、第40145页左栏第2-3段，图1. *
Lisa D.Vailes et al..High-level expression of immunoreactiverecombinant cat allergen (Fel d 1):Targeting to antigen-presenting cells.J ALLERGY CLIN IMMUNOL.2002,110(5),摘要、第758、761页. *
Liselotte Kaiser et al..The Crystal Structure of the Major Cat Allergen Fel d1,a Member of the Secretoglobin Family.THE JOURNAL OF BIOLOGICAL CHEMISTRY.2003,(39),摘要、第37734页右栏第2段. *
LiselotteKaiseretal..TheCrystalStructureoftheMajorCatAllergenFeld1 a Member of the Secretoglobin Family.THE JOURNAL OF BIOLOGICAL CHEMISTRY.2003
刘春国等.病毒样颗粒技术应用的研究进展.中国预防兽医学报.2005,27(2),第159页2.3节. *

Also Published As

Publication number Publication date
CA2599218A1 (en) 2006-09-21
CN103203016A (zh) 2013-07-17
ES2424229T3 (es) 2013-09-30
CY1114171T1 (el) 2016-08-31
BRPI0608455A2 (pt) 2010-01-05
JP5302671B2 (ja) 2013-10-02
ZA200707413B (en) 2009-01-28
US7767212B2 (en) 2010-08-03
JP2008535800A (ja) 2008-09-04
CA2599218C (en) 2015-08-11
DK1868642T3 (da) 2013-06-24
AU2006224529A1 (en) 2006-09-21
IL185103A0 (en) 2007-12-03
MX2007011160A (es) 2007-11-13
US20110045013A1 (en) 2011-02-24
NZ561040A (en) 2009-04-30
CN101141979A (zh) 2008-03-12
AU2006224529B2 (en) 2012-05-24
EP1868642B1 (en) 2013-05-08
US20130344098A1 (en) 2013-12-26
US20090175896A1 (en) 2009-07-09
EP1868642A2 (en) 2007-12-26
PL1868642T3 (pl) 2013-10-31
KR20070112225A (ko) 2007-11-22
WO2006097530A3 (en) 2007-06-21
WO2006097530A2 (en) 2006-09-21
RU2414239C2 (ru) 2011-03-20
PT1868642E (pt) 2013-07-10
JP2013155176A (ja) 2013-08-15
RU2007138265A (ru) 2009-04-27

Similar Documents

Publication Publication Date Title
CN101141979B (zh) 猫变应原融合蛋白及其用途
US8449874B2 (en) Interleukin-1 muteins linked to virus-like particles to treat IL-1 associated diseases
CN101052411B (zh) Vlp-抗原偶联物及其作为疫苗的用途
US20090123414A1 (en) Il-15 Antigen Arrays And Uses Thereof
CN101951943A (zh) 神经生长因子偶联物及其用途
CN101959526A (zh) 白介素-1偶联物在糖尿病治疗中的用途
CA2664418A1 (en) Interleukin-1 muteins linked to virus-like particles to treat il-1 associated diseases
WO2007039458A2 (en) Hiv peptide conjugates and uses thereof
AU2013202547A1 (en) Interleukin-1 conjugates and uses thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130508

Termination date: 20150317

EXPY Termination of patent right or utility model